Core Insights - Strawberry Fields REIT, Inc. reported its best operating results since inception, with significant growth in funds from operations (FFO) and rental revenues in 2025 compared to 2024 [5][6]. Financial Performance - FFO for 2025 was $79.6 million, up from $60.2 million in 2024, representing a growth of 32% [6][25]. - FFO per share increased to $1.43 from $1.15, marking a 24% rise [6][25]. - Adjusted FFO (AFFO) was $72.5 million, compared to $55.8 million in 2024, reflecting a 30% increase [6][25]. - AFFO per share rose to $1.30 from $1.07, a 21% increase [6][25]. - Net income increased to $33.3 million from $26.5 million, driven by higher rental revenues [11][21]. Revenue Growth - Rental revenues increased by $37.9 million, or 32.4%, compared to 2024, primarily due to new leases and acquisitions [6][11]. - The new Kentucky Master Lease contributed $13.1 million to the revenue growth, alongside contributions from acquisitions in Missouri, Kansas, and other states [6][11]. Acquisitions and Leases - The company entered into a new master lease for 10 properties in Kentucky with an annual base rent of $23.3 million, subject to CPI adjustments [4]. - Acquisitions included six facilities in Kansas for $24 million, nine skilled nursing facilities in Missouri for $59 million, and additional properties in Oklahoma and Missouri, totaling over $90 million in investments [4][6]. Expenses - Depreciation expense rose by $6.7 million, or 23.2%, due to new real estate investments [7]. - General and administrative expenses increased by $1.8 million, or 25.6%, primarily from higher payroll costs [8]. - Interest expense increased by $16 million, or 49.1%, mainly due to new bond issuance and additional notes payable [10]. Future Outlook - The company plans to pursue accretive deals while maintaining a disciplined acquisition strategy to sustain growth [5]. - The CEO expressed optimism about the investor perception of the senior housing sector and hopes for the stock price to reflect the company's strengths [5].

Company Overview - BioAge Labs, Inc. is a clinical-stage biotechnology company focused on developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging [3] - The company's lead product candidate, BGE-102, is a small-molecule NLRP3 inhibitor aimed at treating cardiovascular risk and retinal diseases [3] - BioAge is also developing long-acting injectable and oral small molecule APJ agonists for obesity, alongside additional preclinical programs that leverage insights from human longevity data [3] Upcoming Events - BioAge will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25-26, 2026 [1] - CEO Kristen Fortney and CFO Dov Goldstein will participate in a fireside chat and one-on-one meetings during the conference [2] - A live webcast of the presentation will be available, with replays accessible on the company's investor website for 30 days post-event [2] Clinical Development - A Phase 1 SAD/MAD trial of BGE-102 is currently underway, with topline data, including additional MAD cohorts, expected in the first half of 2026 [3]

Core Insights - InterDigital, Inc. has recognized Samir Ferdi as Inventor of the Year for his significant contributions to global wireless standards and innovation in secure, intelligent connectivity [1][2]. Company Overview - InterDigital is a global research and development company focused on wireless, video, artificial intelligence, and related technologies, providing foundational technologies for connected experiences across various products and services [6]. Innovation and Contributions - Samir Ferdi has been with InterDigital since 2007, playing a crucial role in the advancement of 4G and 5G technologies, including vehicle-to-everything (V2X) communications and cellular network security [3][4]. - His work has enabled practical applications in smartphones, IoT devices, and connected automobiles, showcasing the impact of his innovations across multiple industry verticals [3]. Leadership and Vision - InterDigital's CEO, Liren Chen, highlighted Samir's ability to identify challenges and develop forward-looking solutions that have strengthened the company's leadership in wireless research [4]. - The company's CTO, Rajesh Pankaj, emphasized that Samir's leadership in security and standards engagement exemplifies InterDigital's mission to invent technologies that empower a connected world [6].

Core Viewpoint - Host Hotels & Resorts, Inc. has updated its investor presentation for the fourth quarter of 2025, highlighting its position as the largest lodging real estate investment trust in the United States [1]. Company Overview - Host Hotels & Resorts, Inc. is an S&P 500 company and the largest lodging real estate investment trust, owning 71 properties in the United States and five properties internationally, totaling approximately 41,700 rooms [2]. - The company also holds non-controlling interests in seven domestic joint ventures, further expanding its footprint in the hospitality sector [2].

Core Viewpoint - SNDL Inc. is set to release its fourth quarter and full year 2025 financial results on March 12, 2026, before market opening [1] Company Overview - SNDL Inc. is one of the largest vertically integrated cannabis companies in Canada and the largest private-sector liquor and cannabis retailer [2] - The company operates retail banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf [2] - SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future, and Bhang Chocolate [2] - The company aims to deploy strategic capital through direct and indirect investments and partnerships in the North American cannabis industry [2]

Core Viewpoint - U.S. Global Investors, Inc. will host a webcast on February 23, 2026, to discuss its second-quarter results for fiscal year 2026, with financial data to be released beforehand [1]. Group 1: Company Overview - U.S. Global Investors, Inc. has a history of over 50 years, starting as an investment club and evolving into a registered investment adviser focusing on niche markets globally [3]. - The company is headquartered in San Antonio, Texas, and provides investment management and services to U.S. Global Investors Funds and U.S. Global ETFs [3]. Group 2: Webcast Details - The webcast is scheduled for 7:30 a.m. Central time on February 23, 2026, featuring CEO Frank Holmes, CFO Lisa Callicotte, and Director of Marketing Holly Schoenfeldt [1]. - Registration for the webcast is available through a provided link [2].

Core Viewpoint - Olema Pharmaceuticals, Inc. is focused on developing targeted therapies for breast cancer and will present at the TD Cowen 46 Annual Health Care Conference on March 3, 2026 [1] Company Overview - Olema Oncology is a clinical-stage biopharmaceutical company dedicated to improving outcomes for breast cancer patients and is advancing a pipeline of novel therapies [3] - The lead product candidate, palazestrant (OP-1250), is an orally available complete estrogen receptor antagonist and selective estrogen receptor degrader, currently in two Phase 3 clinical trials [3] - Olema is also developing OP-3136, a potent KAT6 inhibitor, which is in a Phase 1 clinical study [3] - The company is headquartered in San Francisco with operations in Cambridge, Massachusetts [3]

Core Insights - Westwood Holdings Group has announced that its Westwood Enhanced Income Series™ ETFs have surpassed $250 million in assets under management (AUM), with the Westwood Salient Enhanced Midstream Income ETF (MDST) specifically reaching $200 million in AUM [1][2][3] Group 1: Company Overview - Westwood Holdings Group is a boutique asset management firm that offers a diverse range of actively and passively-managed investment strategies, focusing on client-first approaches and long-term relationships [6][7] - The firm has over 40 years of experience in providing bespoke investment strategies and exceptional client service, adapting to changing markets with innovative solutions [6][7] Group 2: Product Offerings - The Enhanced Income Series™ includes multiple ETFs aimed at providing income and capital appreciation, with a focus on energy sector investments [3] - The Westwood Enhanced Income Opportunity ETF (YLDW) and the Westwood Salient Enhanced Energy Income ETF (WEEI) are part of this series, designed to generate high distributable monthly income through dividend yields and options premiums [3]

TLA’AMIN TERRITORY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western”) and Qwoqwnes Forestry Holdings Limited Partnership, an entity beneficially owned and controlled by Tla’amin Nation (“Qwoqwnes”), have reached an agreement for the purchase by Qwoqwnes of a 100% ownership interest in the assets comprising Western’s Stillwater Forest Operation, located near Powell River, British Columbia (“BC”), for an aggregate purchase price of $80.0 million (the “Transaction”). The Sti ...

Core Viewpoint - Gran Tierra Energy Inc. has entered into a purchase and sale agreement to sell its remaining working interest in the Simonette asset for a total cash consideration of C$62.5 million, effective January 1, 2026, marking the company's exit from Simonette and focusing on financial strengthening through deleveraging and capital reallocation [1] Financial Transaction - The sale of the Simonette asset will generate cash proceeds of C$62.5 million, which will be used to deleverage the company's balance sheet [1] - The transaction is expected to close in the first quarter of 2026, pending customary closing conditions [1] Strategic Focus - The divestiture aligns with Gran Tierra's strategy of portfolio optimization, emphasizing free cash flow, disciplined capital allocation, and reallocating capital towards higher-return opportunities in core operating areas [1]